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according to Kellgren-Lawrence (K-L) in an AP view X-ray of the
knee. We also recorded the narrowest knee compartment in the
knee with a greater radiographic grade. Pain was evaluated with
a visual analogue scale (VAS) from 0 to 100 mm. Functional
status was evaluated with WOMAC scale and quality of life with
HAQ-DI scale (0-1 low disability, 1-2 moderate and 2-3 severe).
Statistical analysis was accomplished by means of spearman
correlation and a logistic regression model to identify those
variables associated independently with a greater radiographic
grade.
Results: We included 125 patients (102 female/23 male). Mean
age was 65.9 ± 10,1 years. Body mass index (BMI)= 32,2 ±
5,1. Pain referred during the previous week by VAS was 55,5 ±
27,1. They had a total WOMAC of 28,8 ± 18,1, pain-WOMAC
5.6 ± 3,9, stiffness-WOMAC 1,7 ± 1,5, and function WOMAC
21,4 ± 13,9. Radiographic score: 31.2% grade II, 36,8% grade
III and 28,8% grade IV. The medial compartment was the most
commonly affected in 67,7%. Disability was low with an average
of 0.24, only 4% of the patients had moderate or severe disability.
In the univariated analysis we found a signiﬁcant association
between a greater radiographic score and older age (p = 0.001),
greater BMI (p = 0.005), a greater pain-WOMAC (p = 0.001),
greater function-WOMAC (p = 0.001), total-WOMAC (p<0.001)
and HAQ-DI (p<0,001). After adjustment in a logistic regression
model we observed that the variables that were associated
independently with a radiographic grade IV are the BMI (p =
0.046) and HAQ-DI score (p = 0.046). A greater pain, function, and
total-WOMAC were associated with a greater disability according
to HAQ-DI (p = 0.011, p = 0.001 y p = 0.001respectively). We did
not ﬁnd any association between radiographic grade, pain or
disability with the predominant compartment.
Conclusions: Knee osteoarthritis patients have low to moder-
ate grades of pain and disability in our cohort. A greater BMI
and radiographic damage can predict worse functional status
independently of the compartment affected.
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Purpose: Osteoarthritis (OA) is the most prevalent chronic joint
disorder worldwide, affecting more than 7 million people in the
US and responsible for almost 40 million physician visits per
year. The pain caused by OA affecting the knee can be treated
by multiple modalities, including Intra-Articular Hyaluronic Acid
(IA-HA). Different schools of thought exist regarding when in the
treatment algorithm IA-HA should be administered, with concern
regarding how effective the treatment may be in different radio-
graphic stages of OA. We present a further subset analysis of
a double blind study comparing Synvisc® to Euﬂexxa™ utilizing
disease severity deﬁned by the Kellgren-Lawrence (K-L) radio-
graphic scale to deﬁne the treatment groups in order to see if
the pain caused by OA is more resistant or responsive to IA-HA
treatment when administered at different stages of OA.
Methods: The original study was a prospective, multicenter,
randomized double-blind trial evaluating patients with conﬁrmed
osteoarthritis of the knee and a K-L score of either 2 or 3,
using the WOMAC pain subscale as the primary effectiveness
measure. Both products were administered via three weekly
injections, with follow-up evaluations at weeks 3, 6 and 12.
Acetaminophen was permitted as a rescue medicine and was
quantiﬁed by pill counts. The initial interpretation of the data
showed that the effectiveness of Euﬂexxa™ was not inferior to
that of Synvisc®. Further subset analysis evaluates the K-L scale
to deﬁne the cohorts.
Results: Across the two treatment arms, the 167 patients with
a K-L score of 2 had a mean change on the pain subscale
of the WOMAC of 29.1 as detected by a 100-mm VAS from
the initial to the ﬁnal visit; the 147 patients with a K-L score
of 3 had a change of 30.2. The difference between these two
changes is not statistically signiﬁcant. Interestingly, the K-L 2
patients given Euﬂexxa™ and Synvisc® had very comparable
improvements (28.4 vs 29.9, p=0.66), however the K-L 3 patients
given Euﬂexxa™ had numerically more improvement than those
given Synvisc® (33.6 vs 27.2, p=0.05). Euﬂexxa™ patients also
reported greater satisfaction (3.24 vs 3.05 on a 4 point scale
(p=.08)).
Conclusions: In a double blind study, IA-HA is equally effective
when the Kellgren-Lawrence radiographic grade was 2 or 3.
This was true whether the treatment of choice was Euﬂexxa™
or Synvisc®, although a trend towards greater pain relief and
patient satisfaction was seen with Euﬂexxa™.
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Purpose: Avascular necrosis (AVN) develops most frequently in
the femoral head. The disease often causes pain only in the late,
advanced stage. Beta-endorphin (BE), which can be released
both centrally and peripherally is an important indicator of pain
and inﬂammation. The aim of this study was to determine any
difference in the BE level of the synovial ﬂuid at OA patients
compared to the AVN group.
Methods: Synovial ﬂuid was sampled from 10 patients with os-
teoarthritis (OA) of the hip and 10 patients suffering from femoral
head necrosis. The level of beta-endorphin in the synovial ﬂuid
was measured by radioimmunoassay.The 80 % of the AVN group
was Stage IV. and Stage V., 90 % was b or c type. In the OA
group there were two patients with dysplasia of the hip.
Results: The mean of age in the OA group was 63 ± 1.6,
whereas in the AVN group 58 ± 1.8. There was no signiﬁcant
difference between the two groups regarding the age (p=0.45).
The BE-level was 11.08 fmol/ml in the AVN and 6.51 fmol/ml in
the OA group. The difference did not reach p<0.05, but remained
close to it (p=0.09).
On the other hand, comparing the age and the BE level a nega-
tive correlation (R=-0,56) was remarkable, which was signiﬁcant
in the whole population (OA+AVN). This signiﬁcance was mainly
expressed in the AVN group (R=-0.65), whereas the difference in
the OA group is non-signiﬁcant, but it is close to that (R=-0.35).
Conclusions: It is well known from the clinical practice that
the pain-tolerance is higher in the AVN group, which can be
explained by the result that the mean BE value is 70% higher in
case of AVN than in the OA group. Comparing the age and the
BE level a negative correlation was remarkable which might be
to due the impaired activation of suprarenal gland.
